Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Vivozon Pharmaceutical Revenue

Vivozon Pharmaceutical had revenue of 14.11B KRW in the quarter ending March 31, 2026, a decrease of -24.10%. This brings the company's revenue in the last twelve months to 54.86B, down -36.45% year-over-year. In the year 2025, Vivozon Pharmaceutical had annual revenue of 59.34B, down -32.26%.

• Revenue (ttm): 54.86B
• Revenue Growth: -36.45%
• P/S Ratio: 4.44
• Revenue / Employee: 178.71M
• Employees: 307
• Market Cap: 243.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	59.34B	-28.26B	-32.26%
Dec 31, 2024	87.60B	16.28B	22.83%
Dec 31, 2023	71.32B	19.75B	38.31%
Dec 31, 2022	51.56B	-6.00B	-10.42%
Dec 31, 2021	57.56B	13.97B	32.04%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error